Close

Catalyst Biosciences (CBIO) Announces Strong Preclinical Data on CB 2679d/ISU304 in Hemophilia B

Go back to Catalyst Biosciences (CBIO) Announces Strong Preclinical Data on CB 2679d/ISU304 in Hemophilia B